8-K - Maze Therapeutics, Inc. (0001842295) (Filer)
Published . Updated .
Filed: 2026-10-16 AccNo: 0001193125-26-424067 Size: 185 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Directly affected
- MAZE Maze Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-16 AccNo: 0001193125-26-424067 Size: 185 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Maze Therapeutics (MAZE) has moved since 16 Oct 2026
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.63% | final price |
| GLD | the next day | -0.98% | still updating |
| GLD | three days earlier | -1.59% | final price |
| GLD | five days earlier | +0.03% | final price |
| Maze Therapeutics (MAZE) | that day | +7.88% | final price |
| Maze Therapeutics (MAZE) | the next day | +12.62% | still updating |
| Maze Therapeutics (MAZE) | three days earlier | -4.50% | final price |
| Maze Therapeutics (MAZE) | five days earlier | +0.73% | final price |
| QQQ | that day | +1.20% | final price |
| QQQ | the next day | +0.87% | still updating |
| QQQ | three days earlier | +2.70% | final price |
| QQQ | five days earlier | +5.10% | final price |
| SPY | that day | +0.43% | final price |
| SPY | the next day | +0.61% | still updating |
| SPY | three days earlier | +0.83% | final price |
| SPY | five days earlier | +1.93% | final price |
| TLT | that day | -0.72% | final price |
| TLT | the next day | +0.10% | still updating |
| TLT | three days earlier | -1.44% | final price |
| TLT | five days earlier | -2.51% | final price |
Who gains and who loses around Maze Therapeutics (MAZE)
Companies carried with this story
- MAZE Maze Therapeutics
Maze Therapeutics (MAZE) is linked, with no stored direction, high confidence in the 16 Oct 2026 story “8-K - Maze Therapeutics, Inc. (0001842295) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> MAZE
How “8-K - Maze Therapeutics, Inc. (0001842295) (Filer)” reaches Maze Therapeutics (MAZE)
On 16 Oct 2026, “8-K - Maze Therapeutics, Inc. (0001842295) (Filer)” is the story that connects Maze Therapeutics (MAZE) to this story.
For Maze Therapeutics (MAZE), the reason on file says SEC 8-K filing -> direct issuer disclosure -> MAZE
Dates in the story, and the Maze Therapeutics (MAZE) price range
MAZE traded between 23.77 and 30.54 across 12 sessions. The latest close on file is 29.70.
A simple score for Maze Therapeutics (MAZE)
44 out of 100Price not final
“8-K - Maze Therapeutics, Inc. (0001842295) (Filer)” scores 44 out of 100. The score uses 1 sources, a +12.01% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.